www.fdanews.com/articles/67384-kv-pharmaceutical-company-licenses-two-women-s-health-products-for-marketing-in-mexico
KV PHARMACEUTICAL COMPANY LICENSES TWO WOMEN'S HEALTH PRODUCTS FOR MARKETING IN MEXICO
January 10, 2005
KV Pharmaceutical announced today that it has entered into agreements with Representaciones E Investigaciones Medica for the granting of licensing rights in Mexico for KV's two single dose prescription vaginal cream products, U.S. market leader Gynazole-1 and the recently FDA-approved Clindesse. KV will receive licensing fees and manufacturing revenues under the terms of the agreement with RIMSA for both products.
Yahoo News